Treatment of non-healing sternum wound after open-heart surgery with allogenic platelet-rich plasma and fibrin glue-preliminary outcomes

Mohammad Abbasi Tashnizi, Daryoush Hamidi Alamdari, Mohammad Esmail Khayami, Hamid Reza Rahimi, Aliasghar Moeinipour, Ahmad Amouzeshi, Alexander M Seifalian, Mohammad Abbasi Tashnizi, Daryoush Hamidi Alamdari, Mohammad Esmail Khayami, Hamid Reza Rahimi, Aliasghar Moeinipour, Ahmad Amouzeshi, Alexander M Seifalian

Abstract

Introduction: Non-healing wound in the sternal region after coronary arteries bypass graft surgery is a serious complication. For healing a chronic wound, several novel approaches have been proposed recently such as using bone marrow stem cells, platelets and fibrin glue (PFG); but a non-invasive method is highly desirable in the first approach for treatment. The current study was undertaken to evaluate the effect of the combination of PFG in one treatment.

Materials and methods: We report on the treatment of six patients with life-threatening chronic sternum wounds, which caused septicemia with multi-drug resistant pathogens. The ulcers were extensively debrided initially and were measured and photographed at weekly intervals. The combination of PFG was applied topically on the wound after every 2 days.

Results: The wounds were completely closed in five patients and significantly reduced in size in one. There was no evidence of local or systemic complications and any abnormal tissue formation, keloid or hypertrophic scarring.

Conclusions: Our study suggests, in the first approach, PFG can be used safely in order to heal a non healing sternum wound following coronary artery bypass surgery.

Keywords: Chronic wounds; fibrin glue; platelet-rich plasma; sternal wound.

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Wounds treatment out come with a combination of allogenic platelet-rich plasma and fibrin glue

References

    1. Sharma RK, John JR. Role of stem cells in the management of chronic wounds. Indian J Plast Surg. 2012;45:237–43.
    1. Sen CK, Gordillo GM, Roy S, Kirsner R, Lambert L, Hunt TK, et al. Human skin wounds: A major and snowballing threat to public health and the economy. Wound Repair Regen. 2009;17:763–71.
    1. Harding KG, Morris HL, Patel GK. Science, medicine and the future: Healing chronic wounds. BMJ. 2002;324:160–3.
    1. Ravari H, Hamidi-Almadari D, Salimifar M, Bonakdaran S, Parizadeh MR, Koliakos G. Treatment of non-healing wounds with autologous bone marrow cells, platelets, fibrin glue and collagen matrix. Cytotherapy. 2011;13:705–11.
    1. Schimmer C, Sommer SP, Bensch M, Leyh R. Primary treatment of deep sternal wound infection after cardiac surgery: A survey of German heart surgery centers. Interact Cardiovasc Thorac Surg. 2007;6:708–11.
    1. Juhl AA, Koudahl V, Damsgaard TE. Deep sternal wound infection after open heart surgery — Reconstructive options. Scand Cardiovasc J. 2012;46:254–61.
    1. Silver FH, Wang MC, Pins GD. Preparation and use of fibrin glue in surgery. Biomaterials. 1995;16:891–903.
    1. Kachel E, Callum J, Moussa F, Goldstein J, Fremes S. Treatment of deep sternal wound infections after coronary artery bypass grafting by means of injection of platelet gel: An evolving technology. J Thorac Cardiovasc Surg. 2010;139:e118–20.
    1. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: From basic science to clinical applications. Am J Sports Med. 2009;37:2259–72.
    1. Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Król W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: An in vitro study. J Bone Joint Surg Br. 2007;89:417–20.
    1. Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun. 2002;70:6524–33.
    1. Laurens N, Koolwijk P, de Maat MP. Fibrin structure and wound healing. J Thromb Haemost. 2006;4:932–9.
    1. Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care. 2001;24:483–8.
    1. Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, et al. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci. 2004;30:145–51.
    1. Driver VR, Hanft J, Fylling CP, Beriou JM Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage. 2006;52:68–70. 72, 74 passim.
    1. Jeong SH, Han SK, Kim WK. Treatment of diabetic foot ulcers using a blood bank platelet concentrate. Plast Reconstr Surg. 2010;125:944–52.
    1. Chen TM, Tsai JC, Burnouf T. A novel technique combining platelet gel, skin graft, and fibrin glue for healing recalcitrant lower extremity ulcers. Dermatol Surg. 2010;36:453–60.
    1. Sell SA, Ericksen JJ, Reis TW, Droste LR, Bhuiyan MB, Gater DR. A case report on the use of sustained release platelet-rich plasma for the treatment of chronic pressure ulcers. J Spinal Cord Med. 2011;34:122–7.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj